A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!
作者信息
Zhang Yongneng, Michelakis Evangelos D
机构信息
Department of Medicine University of Alberta Edmonton, Alberta, Canada.
出版信息
Am J Respir Crit Care Med. 2021 Jul 15;204(2):123-125. doi: 10.1164/rccm.202103-0612ED.
Abstract
摘要
Zotero 插件